Top Markets
Coin of the day
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp.

4171
Rangering i aksjer #27717
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes... GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
Aksjekurs
$0.54853323
Markedsverdi
$31.43M
Endring (1 dag)
0.58%
Endring (1 år)
-18.14%
Land
TW
Handel GeneReach Biotechnology Corp. (4171)

Kategori

Inntekter for GeneReach Biotechnology Corp. (4171)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til GeneReach Biotechnology Corp. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for GeneReach Biotechnology Corp. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$12.62B -
US
$2.23B -
US
$6.02B -
NL
$15.70B -
AU
- -
CH